A Phase II Pilot Trial of Sutent, Tamoxifen, and Cisplatin in Patients With High-Risk Ocular Melanoma
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cisplatin (Primary) ; Sunitinib (Primary) ; Tamoxifen (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 17 Aug 2007 New trial record.